Genome-wide association identifies a susceptibility locus for coronary artery disease in the Chinese Han population

Journal name:
Nature Genetics
Year published:
Published online

Coronary artery disease (CAD) causes more than 700,000 deaths each year in China. Previous genome-wide association studies (GWAS) in populations of European ancestry identified several genetic loci for CAD, but no such study has yet been reported in the Chinese population. Here we report a three-stage GWAS in the Chinese Han population. We identified a new association between rs6903956 in a putative gene denoted as C6orf105 on chromosome 6p24.1 and CAD (P = 5.00 × 10−3, stage 2 validation; P = 3.00 × 10−3, P = 1.19 × 10−8 and P = 4.00 × 10−3 in three independent stage 3 replication populations; P = 4.87 × 10−12, odds ratio = 1.51 in the combined population). The minor risk allele A of rs6903956 is associated with decreased C6orf105 mRNA expression. We report the first GWAS for CAD in the Chinese Han population and identify a SNP, rs6903956, in C6orf105 associated with susceptibility to CAD in this population.


  1. Lopez, A.D., Mathers, C.D., Ezzati, M., Jamison, D.T. & Murray, C.J. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 367, 17471757 (2006).
  2. Sing, C.F., Stengard, J.H. & Kardia, S.L. Genes, environment, and cardiovascular disease. Arterioscler. Thromb. Vasc. Biol. 23, 11901196 (2003).
  3. Wang, Q. Molecular genetics of coronary artery disease. Curr. Opin. Cardiol. 20, 182188 (2005).
  4. Broeckel, U. et al. A comprehensive linkage analysis for myocardial infarction and its related risk factors. Nat. Genet. 30, 210214 (2002).
  5. Wilson, P.W. et al. Prediction of coronary heart disease using risk factor categories. Circulation 97, 18371847 (1998).
  6. Khot, U.N. et al. Prevalence of conventional risk factors in patients with coronary heart disease. J. Am. Med. Assoc. 290, 898904 (2003).
  7. Gibbons, G.H. et al. Genetic markers: progress and potential for cardiovascular disease. Circulation 109, IV47IV58 (2004).
  8. Marenberg, M.E., Risch, N., Berkman, L.F., Floderus, B. & de Faire, U. Genetic susceptibility to death from coronary heart disease in a study of twins. N. Engl. J. Med. 330, 10411046 (1994).
  9. Wilson, P. Established risk factors and coronary artery disease: the Framingham Study. Am. J. Hypertens. 7, 7S12S (1994).
  10. Hirschhorn, J.N. & Daly, M.J. Genome-wide association studies for common diseases and complex traits. Nat. Rev. Genet. 6, 95108 (2005).
  11. McPherson, R. et al. A common allele on chromosome 9 associated with coronary heart disease. Science 316, 1488 (2007).
  12. Samani, N.J. et al. Genomewide association analysis of coronary artery disease. N. Engl. J. Med. 357, 443 (2007).
  13. Willer, C.J. et al. Newly identified loci that influence lipid concentrations and risk of coronary artery disease. Nat. Genet. 40, 161169 (2008).
  14. Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447, 661678 (2007).
  15. Trégouët, D.A. et al. Genome-wide haplotype association study identifies the SLC22A3-LPAL2-LPA gene cluster as a risk locus for coronary artery disease. Nat. Genet. 41, 283285 (2009).
  16. Myocardial Infarction Genetics Consortium. et al. Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants. Nat. Genet. 41, 334341 (2009).
  17. Helgadottir, A. et al. The same sequence variant on 9p21 associates with myocardial infarction, abdominal aortic aneurysm and intracranial aneurysm. Nat. Genet. 40, 217224 (2008).
  18. Gudbjartsson, D.F. et al. Sequence variants affecting eosinophil numbers associate with asthma and myocardial infarction. Nat. Genet. 41, 342347 (2009).
  19. Shen, G.Q. et al. Four SNPs on chromosome 9p21 in a South Korean population implicate a genetic locus that confers high cross-race risk for development of coronary artery disease. Arterioscler. Thromb. Vasc. Biol. 28, 360365 (2008).
  20. Schunkert, H. et al. Repeated replication and a prospective meta-analysis of the association between chromosome 9p21. 3 and coronary artery disease. Circulation 117, 16751684 (2008).
  21. Assimes, T.L. et al. Susceptibility locus for clinical and subclinical coronary artery disease at chromosome 9p21 in the multi-ethnic ADVANCE study. Hum. Mol. Genet. 17, 23202328 (2008).
  22. Zhou, L. et al. Associations between single nucleotide polymorphisms on chromosome 9p21 and risk of coronary heart disease in Chinese Han population. Arterioscler. Thromb. Vasc. Biol. 28, 20852089 (2008).
  23. Seo, J., Kim, J. & Kim, M. Cloning of androgen-inducible gene 1 (AIG1) from human dermal papilla cells. Mol. Cells 11, 3540 (2001).
  24. Hanke, H., Lenz, C., Hess, B., Spindler, K.D. & Weidemann, W. Effect of testosterone on plaque development and androgen receptor expression in the arterial vessel wall. Circulation 103, 13821385 (2001).
  25. Wu, F.C. & von Eckardstein, A. Androgens and coronary artery disease. Endocr. Rev. 24, 183217 (2003).
  26. Shen, G.Q. et al. An LRP8 variant is associated with familial and premature coronary artery disease and myocardial infarction. Am. J. Hum. Genet. 81, 780791 (2007).
  27. Zhang, X. et al. Mutation in nuclear pore component NUP155 leads to atrial fibrillation and early sudden cardiac death. Cell 135, 10171027 (2008).
  28. Bustin, S.A. et al. The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin. Chem. 55, 611622 (2009).

Download references

Author information

  1. These authors contributed equally to this work.

    • Fan Wang,
    • Cheng-Qi Xu,
    • Qing He,
    • Jian-Ping Cai,
    • Xiu-Chun Li,
    • Dan Wang,
    • Xin Xiong,
    • Yu-Hua Liao,
    • Qiu-Tang Zeng,
    • Yan-Zong Yang &
    • Xiang Cheng


  1. Key Laboratory of Molecular Biophysics of the Ministry of Education, Cardio-X Institute, College of Life Science and Technology and Center for Human Genome Research, Huazhong University of Science and Technology, Wuhan, China.

    • Fan Wang,
    • Cheng-Qi Xu,
    • Xiu-Chun Li,
    • Dan Wang,
    • Xin Xiong,
    • Cong Li,
    • Rong Yang,
    • Chu-Chu Wang,
    • Qiu-Lun Lu,
    • Ying Bai,
    • Yu-Feng Huang,
    • Dan Yin,
    • Qing Yang,
    • Xiao-Jing Wang,
    • Si-Si Li,
    • Yuan-Yuan Zhao,
    • Fen-Fen Fu,
    • Yuan Huang,
    • Nan Wang,
    • Chun-Yan Luo,
    • Li-Ying Ji,
    • Lei Li,
    • Hui Liu,
    • Er-Wen Huang,
    • Jin Cui,
    • Xiang Ren,
    • Hui Li,
    • Tie Ke,
    • Xian-Qin Zhang,
    • Jing-Yu Liu,
    • Mu-Gen Liu,
    • Li-Song Shi,
    • Xin Tu &
    • Qing K Wang
  2. Beijing Hospital, Ministry of Health, Beijing, China.

    • Qing He,
    • Jian-Ping Cai,
    • Da-Peng Dai &
    • Na Jia
  3. Institute of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

    • Yu-Hua Liao,
    • Qiu-Tang Zeng &
    • Xiang Cheng
  4. First Affiliated Hospital of Dalian Medical University, Dalian, China.

    • Yan-Zong Yang,
    • Rong-Feng Zhang,
    • Lian-Jun Gao &
    • Yun-Long Xia
  5. Renmin Hospital of Wuhan University, Wuhan, China.

    • Gang Wu,
    • Hao Xia &
    • Bo Yang
  6. Zhongnan Hospital of Wuhan University, Wuhan, China.

    • Jing Wan &
    • Jiang-Hua Ren
  7. Affiliated Hospital of Jining Medical Collage, Shandong, China.

    • Qing-Xian Li,
    • Sheng-Wei Shi &
    • Nan Lin
  8. Department of Pharmacology, Harbin Medical University, Harbin, China.

    • Zhen-Wei Pan
  9. The First Affiliated Hospital, Harbin Medical University, Harbin, China.

    • Yue Li
  10. The Second Affiliated Hospital, Harbin Medical University, Harbin, China.

    • Bo Yu
  11. The First Hospital of Wuhan City, Wuhan, China.

    • Yan-Xia Wu,
    • Yu-He Ke &
    • Jian Lei


Study concept and design: Q.K.W., J.-P.C., X.T., Q.H. and M.-G.L.

Acquisition of data: C.-Q.X., Q.H., J.-P.C., X.-C.L., D.W., X.X., Y.-H.L., Q.-T.Z., X.C., Y.-Z.Y., C.L., R.Y., C.-C.W., G.W., Q.-L.L., Y.B., Y.-F.H., D.Y., Q.Y., X.-J.W., D.-P.D., R.-F.Z., J.W., J.-H.R., S.-S.L., Y.-Y.Z., F.-F.F., Y.H., Q.-X.L., S.-W.S., N.L., Z.-W.P., Y.L., B.Y., Y.-X.W., Y.-H.K., J.L., N.W., C.-Y.L., L.-Y.J., L.-J.G., L.L., H. Liu, E.-W.H., J.C., N.J., X.R., H. Li, T.K., X.-Q.Z., J.-Y.L., H.X., B.Y., L.-S.S. and Y.-L.X.

Analysis and interpretation of data: C.-Q.X., F.W., D.-P.D., J.-P.C., L.-S.S., X.-C.L., D.W., X.X., Q.H., X.T. and Q.K.W.

Drafting of the manuscript: C.-Q.X., F.W. and X.T.

Critical revision of the manuscript: Q.K.W., F.W. and C.-Q.X.

Statistical analysis: F.W. and C.-Q.X.

Study supervision: Q.K.W., Q.H., J.-P.C., X.T., Y.-H.L. and Y.-Z.Y.

Competing financial interests

The authors declare no competing financial interests.

Corresponding authors

Correspondence to:

Author details

Supplementary information

PDF files

  1. Supplementary Text and Figures (2M)

    Supplementary Figures 1–4 and Supplementary Tables 1–4.

Additional data